Quoin Pharmaceuticals (QNRX) Operating Leases (2019 - 2020)

Quoin Pharmaceuticals (QNRX) posted Operating Leases of $122000.0 for Q4 2020, down 21.29% sequentially from $155000.0 in Q2 2020.

Quoin Pharmaceuticals (QNRX) Operating Leases (2019 - 2020) Analysis & Trends

Quoin Pharmaceuticals has reported Operating Leases for 2 years, with the latest figure at $122000.0 in Q4 2020.

Quarterly Operating Leases changed N/A year-over-year to $122000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $122000.0 (changed N/A YoY) and the FY2020 annual result came in at $122000.0, changed N/A from the prior year.
Operating Leases fell to $122000.0 in Q4 2020 per QNRX's latest filing, from $155000.0 in the prior quarter.
Over five years, Operating Leases peaked at $243000.0 in Q2 2019 and troughed at $122000.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	Quoin Pharmaceuticals	491,038.58	491,038.58	-

Download Data